Piper Sandler Sees 5 Reasons Aligos Therapeutics Inc. (ALGS) HBV Pipeline Remains Best in Class

Go back to Piper Sandler Sees 5 Reasons Aligos Therapeutics Inc. (ALGS) HBV Pipeline Remains Best in Class
(NASDAQ: ALGS) Delayed: 5.02 +0.27 (5.68%)
Previous Close $4.75    52 Week High $ 
Open $4.89    52 Week Low $ 
Day High $5.14    P/E N/A 
Day Low $4.72    EPS $ 
Volume 27,845